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Seventy-seven patients with morbid obesity, body mass index (BMI) 40–69?9 kgm72, who were candidates for
gastroplasty, were studied in our laboratory as part of a pre-operative survey. They had no complaints other than
obesity and were not cyanotic. A group of 28 lean subjects (BMI 20–29?8 kgm72) who were candidates for
abdominal surgery, without any respiratory complaint, were included as controls. For each patient a pulmonary
function test was performed, measuring slow vital capacity with expiratory residual volume (ERV), forced vital
capacity (flow/volume) and maximal voluntary ventilation (MVV).
In obese patients the MVV is reduced as BMI increases. This results in the reduction of expiratory flows and
volumes. Forced expiratory volume in 1 sec (FEV1) is reduced in proportion to the FVC reduction and is related to
MVV. It is suggested that the main consequence of the burden of the chest wall by increased adipose mass is a
reduction in its compliance, making inspiration increasingly dicult, and resulting in lower static volumes and
flows.
Key words: obesity; maximal voluntary ventilation; body mass index; chest wall compliance; expiratory flows;
inspiratory flows.
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Morbid obesity may hinder respiratory function even in the
absence of other diseases. Chen et al. (1), in a 6-year follow-
up study in Canada, reported a decline of pulmonary
function closely related to weight gain. Increased body mass
index (BMI) results in an increased mass on the chest wall,
including the rib cage, affecting thoracic expansion and
leading to restrictive impairment of pulmonary function. In
these patients respiratory compliance is reported to be
reduced (2–8). However, Suratt et al. (9), using the pulse-
flow method, did not find any correlation between BMI and
chest wall compliance.
Mechanical impairment has been described (10–14) in
obese patients, and is characterized by reduction of
maximal voluntary ventilation (MVV). This has not been
widely confirmed, as Dempsey et al. (15) and Kolias et al.
(16) described that in patients with slightly increased BMI
(around 40 kgm72) values for MVV were found to be
normal. Ray et al. (17) described a reduction of MVV when
the weight/height ratio exceeds 0?90, and Sahebjami et al.
(18) found normal or low MVV depending on the subject’s
weight. The deficiency in chest wall mechanics is probably
due to the burden induced by increased adipose tissue overReceived and accepted 2 January 2001.
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0954-6111/01/040281+06 $35?00/0the chest. This was experimentally demonstrated by Caro
et al. by strapping the chest wall (19).
Flow and static volumes have been described as normal
(3,5,10,12,20–24) or decreased (15–18,25–26). There is,
however, general agreement that expiratory residual
volume (ERV) is significantly reduced (2,3,5,6,13–15,
20, 21, 24–26) in the obese patient, and that it is related
to BMI. A relationship between the reduction of ERV and
that of ventilation/perfusion (V/Q) had been also described
(22,25).
This study was undertaken to determine the influence of
body mass on chest wall mechanics, the degree of alteration




General surgery patients, endocrinology outpatients and
candidates for gastroplasty with a diagnosis of morbid
obesity (98 patients in total) were reported to us for pre-
operative pulmonary evaluation. Only patients with a BMI
greater than 40 kgm72 were selected, reducing the number
of candidates to 84. All subjects, in spite of their obesity,
were in good health and none presented with sputum,
cough or cyanosis. At spirometry, patients that presented a
back-extrapolated volume of forced vital capacity (FVC)
higher than 5% or could not perform a good expiratory# 2001 HARCOURT PUBLISHERS LTD
282 W. LADOSKY ET AL.effort, according to the Brazilian (27), ATS (28) or ECCS
(29) consensus for spirometry, were discarded from the
study. The final group was therefore reduced to 77 patients
(19 males and 59 females) aged from 21 to 59 years, with a
BMI ranging from 40?9 to 69?98 kgm72.
The control group was composed of 28 subjects (10
males, 18 females), ranging from 21 to 56 years of age,
without any pulmonary complaints. Their pulmonary
function was evaluated before abdominal surgery and all
had normal thorax RX. Voluntary medical students were
also included as controls. All control group participants
were selected on the basis of BMI ranging from 20 to
29 kgm72 and normal forced spirometry.
EQUIPMENT
A fluxometric spirometer (Beatrice, EBEM Inc., Recife,
Brazil) using a Fleisch IV Pneumotachometer linked to a
differential pressure transducer (Celesco, California,
U.S.A.) meeting international standards, was used. The
software permitted a high precision of inspiratory and
expiratory flow and was therefore also suitable for the
MVV measurement. As well the measurements for the
flow–volume curve it also measured the back-extrapolated
volume (BEV) and compared it to the FVC (BEV in FVC%).
FUNCTION TESTS
Ventilatory function was assessed by measuring vital
capacity (VC), FVC and MVV, in that order.
All tests were performed in the morning with patients
seated. Each one the patients performed at least four tests.
For VC measurement the best value was selected and from
this manoeuvre the ERV was obtained. The flow–volume
curve was calculated according to the method of D’Angelo
et al. (30) and the best FVC  forced expiratory volume
(FEV1) was selected, provided that their FVC did not differTABLE 1. Spirometric values and subject data of lean and obese
Controls Group A (n
Sex (M/F) 10/18 6/30
Age 21–56 21–51
BMI (kgm72) 24?79 (1?15) 45?90 (2?49
FVC % 99?04 (2?47) 89?37 (2?99
FEV1% 97?01 (2?62) 86?96 (3?10
TI 90?39 (1?13) 88?73 (0?77
ERV (ml) 885 (53) 502 (63)a
MVV % 124?18 (5?19) 104?12 (5?05
FEF 50% 141?04 (9?66) 101?86 (4?85
PEF % 97?18 (5?18) 90?71 (4?07
PIF % 87?75 (5?33) 73?63 (6?05
FIF 50% 133?32 (8?12) 108?79 (5?91
Group A: BMI 40–49?99 kgm72; group B: BMI 50–59?99 kgm
aP50?05; bP50?01; cP50?005 (all results expressed as mean +by more than 5% or the difference was not greater than
200ml. To calculate predicted values the equations
proposed by Pereira et al. (31) for the Brazilian population
were adopted. Spirometric diagnoses were made according
to the Brazilian Consensus of Spirometry (27).
For MVV patients were asked to perform a sequence of
forced inspirations and expirations over 12 sec, within a
frequency of 30–50min71. The highest value over five trials
was taken for analysis. The equations proposed by Kory
et al. (32) for men and Lindall et al. (33) for women were
used to calculate the predicted values.
STATISTICS
Epidemiology statistics software from The Emory Uni-
versity, Atlanta, GA, U.S.A. (Epi 6a) for epidemiological
analysis was used. To analyse differences between means an
ANOVA test was used; to compare diagnostics differences
the w2-test was used.
Results
Table 1 shows general data of the subjects and spirometric
results obtained.
Data collected were divided in three groups according to
patients’ BMI. Group A included subjects with BMI of 40–
49?99 kgm72; group B had BMI of 50–59?99 kgm72; group
C had BMI of 60–69?99 kgm72. Results are presented in
Table 1 and the best fit line for MVV and BMI are shown in
Fig. 1.
DIAGNOSTICS
No obstructive or combined spirometric impairment was
detected in any group of obese subjects. By selection all lean
subjects were spirometrically normal. As seen in Table 2,patients
36) Group B (n 32) Group C (n 9)
9/23 4/5
24–59 22–44
) 54?40 (2?54) 63?50 (4?34)
)a 80?16 (3?04)c 73?12 (2?27)c
)a 76?91 (3?29)c 72?86 (4?29)c
) 87?53 (1?46) 86?00 (2?65)
300 (56)c 243 (20)c
)b 93?71 (5?24)c 75?35 (5?03)c
)c 101?72 (5?79)c 83?75 (9?85)c
)c 90?10 (6?48)c 85?67 (5?69)c
)a 67?84 (4?21)c 57?33 (4?52)c
)a 108?82 (7?23)a 86?00 (9?39)a
72; group C: BMI 60–99 kgm72.
SD)
FIG. 1. Best fit line for control lean subjects (left) and
obese patients (right). Dashed line represents 5%
deviations. Each cross represents subjects outside
deviation. In lean normal subjects MVV increases with
higher MVV. In obese patients there is a significant
inverse correlation.
TABLE 2. Spirometric diagnostics in lean controls and obese
patients
Diag./BMI Normal Group A Group B Group C
Normal 28 18 12 1
Restrictive – 18 20 8
%restrictive/normal 0 50 63 89
FIG. 2. Mean and standard error for MVV, FVC and
FEV1 in control group (N), obese with BMI between 40
and 49?9 kgm72 (A), between 50 and 59?9 kgm72 (B) and
between 60 and 69?99 kgm72(C). Continuous line links
points representing mean +SEM of BMI in each group.
Dashed line represents almost unchanged Tiffeneau index.
CHEST MECHANICS IN MORBIDLY OBESE PATIENTS 283the incidence of restrictive pulmonary impairment increases
proportionally with increase in BMI.
MVV
Increase in BMI induces a highly significant decrease of
MVV (t 2?18, P50?01) but the negative correlation was
non-linear (r70?12). These results become more im-
pressive when compared to data from lean subjects, where
the relationship between BMI and MVV is positive and
more linear (r 0?34). As seen in Fig. 1 this correlation is
reversed when obese and lean subjects are compared.
STATIC VOLUMES
As shown in Fig. 2 FVC and FEV1 decrease in obese
patients as BMI increases. In group A both are already
significantly lower (P50?05) when compared to lean
controls. The reduction of expiratory volumes is closely
related to reduction of the MVV, and is a consequence of
the increase in BMI. In group C volumes are severely
reduced and are significantly different from group A
(P 0?001) (Table 1). However the Tiffeneau index (TI)
remains constant in all groups and comparable to normalcontrols. As presented in Table 1 ERV is significantly
reduced in all groups and follows the reduction of MVV.
FLOWS
Instant expiratory and inspiratory flows are reduced in
obese subjects as long as MVV is reduced as a consequence
of increased BMI (Table 1). The ratio of peak flow to MVV
in obese patients is lower when compared to leans subjects,
indicating a more important decrease of MVV than peak
expiratory flow (PEF). The same was observed for instant
flows at median and low volumes (Table 3).
The ratio between PEF and peak inspiratory flow (PIF),
which is around 1 in leans subjects, increases significantly as
BMI increases (Fig. 3, Table 4). The ratio between FEF50
and FIF50, however, does not change significantly in obese
patients, and is comparable to normal leans subjects.
Discussion
The high percentage value of MVV found for the control
group suggests that the predicted value for the Brazilian
population must be different, and probably higher, than
that proposed by Kory et al. (32) for male and by Lindall
et al. (33) for female American subjects. However, as this is
a constant error depending on a permanent factor, the
results obtained may be interpreted and compared to the
other parameters observed. It is evident that a study to
determine the predicted MVV value for a Brazilian
population should be done; this is already underway.
As observed in Fig. 1, an increase in BMI induces a
significant reduction of MVV. In the control group, with
BMI 20–29?9 kgm72 (mean+ SD 24?79+1?15 kgm72),
the increase in body weight corresponds to a slightly
greater MVV, perhaps indicating a better chest wall
performance. However, in morbidly obese patients, increase
TABLE 3. Relationship between MVV and flows
Lean Group A Group B Group C
MVV/FEF50 38?8 (3?29) 27?96 (1?43)a 29?52 (2?17)a 26?32 (2?26)a
MVV/FEF75 95?36 (7?18) 81?35 (4?97) 81?48 (7?82) 61?32 (5?77)a
MVV/PEF 94?17 (5?80) 90?71 (4?07) 90?1 (6?48) 87?61 (5?69)
MVV/FIF50 25?77 (3?38) 25?10 (1?70) 27?55 (92?01) 26?23 (2?74)
MVV/FIM 23?67 (3?51) 24?68 (1?32) 24?11 (1?60) 23?22 (2?20)
Results calculated from Table 1 and represent the mean ratio between MVV and the corresponding flow in each group. Data
are mean (+SEM).
aP50?05.
FIG. 3. Graphical representation of Table 4. Line
represents the best fit for MVV, points representing mean
+SEM in each group. Bars represent the relationship
between peak expiratory/inspiratory flows (dashed) and
median expiratory/inspiratory flows (crossed) in control
group (N), obese with BMI 40–49?9 kgm72 (A), 50–
59?99 kgm72 (B) and 60–69?99 kgm72 (C).
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MVV. These results are in agreement with some others
studies in the literature (10–14). As Dempsey et al. (15) and
Kolias et al. (16) found a normal MVV in obese patients,
we re-calculated the BMI of their subjects and found a
mean around 44 for the former and 37 for the latter. It is
therefore possible that they have studied patients who have
not reached a BMI high enough to hinder the chest wall
mechanics.
The MVV manoeuvre represents the integration of many
factors in the pulmonary mechanics such as endurance,
airway diameter and respiratory muscle strength (34–37),
and is related to chronic airway obstruction (38). In our
patients MVV, FVC and FEV1 were correlated to BMI. In
Fig. 2 it can clearly be observed that an increase of BMI
corresponds to a decrease of the other three parameters. In
contrast to the results found by Suratt et al. (9), we
observed that in each obese group, FVC and FEV1 are
significantly reduced. This has also been described by others
(2,4,24) and closely follows the decrease in MVV. This
strengthens the point that FVC is reduced probably as
consequence of the decrease of the elastic property of thechest wall, leading to diminution of its compliance (5) and,
therefore, to the reduction of lung volumes (28); in this
case, evaluated as reduction of MVV. FVC and FEV1 also
follow such a decrease. The Tiffeneau index, however,
shows a comparable value among the groups and is
comparable to that observed in normal patients. Therefore,
the reduction of FEV1 may just be a consequence of FVC
reduction, which is also the result of MVV reduction due to
lower chest wall compliance.
FEV1 and MVV have been suggested to be indicative of
obstructive impairment (36,37). However, the reduction of
the expiratory flows could be considered as a result of
the diminution of MVV. We therefore suggest that the
reduction observed in FEV1 is not due to an impairment or
reduction of the bronchial diameter, but follows the
reduction of MVV and the failure in chest wall mechanics,
which is also a consequence of increased weight over the
chest.
Inspiratory flows are influenced by the mechanical
properties of the lung and the chest wall, in this case
through inspiratory muscle strength (39). Decrease of
inspiratory flows (Table 1) indicates an increase in air
trapping, which is correlated to the reduction of MVV,
following an increase in BMI. This is confirmed by the
reduction of ERV in the same proportion in each group of
obese patients. ERV has been described to be the most
affected expiratory parameter in obese patients (14), which
has been extensively confirmed (2–6,13,15,22,24–26), in-
cluding results from our subjects. As ERV depends on
respiratory muscles strength and chest wall compliance its
decrease in obesity is due to the reduction of MVV in
consequence of the increased loading of the chest wall (4).
ERV reduction may be followed by a reduction in V/Q,
which leads to a reduction of FVC (22,25). As our patients
were not hypoventilated this is probably not the case in our
study.
PEF is effort-dependent and is related to how fast pleural
pressure can be increased at the beginning of the forced
expiration (40). It is also dependent on the force applied to
the chest wall and its elasticity (41). D’Angelo et al. (30,42)
demonstrated that the decrease in lung elastic recoil
accounts for PEF reduction, even in normal subjects.
On the other hand the PIF depends on muscular
drive, especially that of the diaphragm, and chest wall
TABLE 4. Relationship between maximal expiratory and maximal inspiratory flows as well as median expiratory and
inspiratory instant flows in obese individuals and control leans subjects
Lean Group A Group B Group C
PEF/PIF 1?08 (0?06) 1?27 (0?06) 1?33 (1?00) 1?49 (0?09)
FEF50/FIF50 1?00 (0?06) 0?98 (0?05) 0?99 (0?08) 0?96 (0?06)
CHEST MECHANICS IN MORBIDLY OBESE PATIENTS 285compliance. A significant reduction of PEF and PIF was
observed in our obese subjects, especially in those with BMI
higher than 50 kgm72. This closely follows the reduction of
MVV and also supports the hypothesis that in obese
patients the increased weight over the chest wall affects its
mechanics, causing a significant reduction in MVV and,
therefore, reduction in volumes and flows.
As seen in Table 4 the ratio between PEF and PIF
increases in all group of obese patients with increase in
BMI. This indicates that inspiratory drive is more affected
in obese patients than expiratory mechanics, probably due
to lower chest wall compliance. Further studies in
diaphragmatic mechanics and trans-diaphragmatic pres-
sures are necessary to confirm these suggestions.
The same increase, however, was not observed when the
ratio of FEF50 : FIF50 was analysed, suggesting that
the medium flows are less affected by lower compliance of
the chest wall in obese subjects.
These results support the idea that the first consequence
of increased mass over the chest in the morbidly obesity is
the reduction of chest wall compliance. This leads to a
reduction of MVV, the consequence of which is lower
values for FVC indicating a restrictive impairment. This
becomes more frequent and more serious as BMI increases.
As the reduction in FEV1 and PEF follows that of FEV1
with normal TI, conclude that these impairments are a
consequence of the reduction of FVC and are not indicative
of airways obstruction.
Acknowledgements
The authors wish to thank Mr Jose´ Edilson Anasta´cio
Rocha for his skilful technical assistance.
References
1. Chen Y, Horne SL, Dosman J. Body weight and weight
gain related to pulmonary function decline in adults: a
six year follow up study. Thorax 1993; 48: 375–380.
2. Bedell GN, Wilson WR, Seebohm PM. Pulmonary
function in obese persons. J Clin Invest 1958; 37: 1049–
1060.
3. Naimark A, Cherniack RM. Compliance of respiratory
system and its components in health and obesity. J
Appl Physiol 1960; 15: 337–382.4. Sharp JT, Henry JP, Sweany SK, Meadows WR,
Pietras RJ. The total work of breathing in normal and
obese men. J Clin Invest 1961; 43: 728–739.
5. Cherniack RM, Guenter CA. The eciency of the
respiratory muscles in obesity. Can J Biochem Physiol
1961; 39: 1215–1222.
6. Gilbert R, Sipple JH, Auchincloss JHJ. Respiratory
control and work of breathing in obese subjects. J Appl
Physiol 1961; 16: 21–26.
7. Rochester DF, Enson Y. Current concepts in the
pathogenesis of the obesity–hypoventilation syndrome.
Am J Med 1974; 57: 402–420.
8. Luce JM. Respiratory complication of obesity. Chest
1980; 78: 626–631.
9. Suratt PM, Wilholt SC, Hsiao HS, Atkinson RL,
Rochester DF. Compliance of chest wall in obese
subjects. J Appl Physiol 1984; 57: 403–407.
10. Kaufman BJ, Ferguson MH, Cherniack RM. Hypo-
ventilation in obesity. J Clin Invest 1959; 38: 500–507.
11. Hackney DD, Crave MG, Collier CR, Rockaw S,
Griggs DE. Syndrome of extreme obesity and hypo-
ventilation: studies on etiology. Ann Inter Med 1959;
51: 541–522.
12. Wadstro¨m C, Mu¨ller-Suur R, Backman L. Influence of
excessive weight loss on respiratory function. Eur J
Surg 1961; 157: 341–346.
13. Cullen JH, Formel PF. The respiratory defects in
extreme obesity. Am J Med 1962; 32: 531–525.
14. Emirgil C, Sobol BJ. The effects of weight reduction on
pulmonary function and the sensitivity of the respira-
tory centre in obesity. Am Rev Resp Dis 1973; 108: 831–
842.
15. Dempsey JA, Reddan W, Rankin J, Balke B. Alveolar–
arterial gas exchange during muscular work in obesity.
J Appl Physiol 1966; 21: 1897–1814.
16. Kollias J, Boileau RA, Bartlett HL, Buskirk ER.
Pulmonary function and physical conditioning in lean
and obese patients. Arch Environ Health 1972; 25: 146–
150.
17. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K.
Effects of obesity on respiratory function. Am Rev Resp
Dis 1983; 128: 501–506.
18. Sahebjami H, Garstide PS. Pulmonary function in
obese subjects with a normal FEV1/FVC ratio. Chest
1996; 110: 1425–1429.
19. Caro CG, Butler J, Dubois AB. Some effects of
restriction of chest cage expansion on pulmonary
function in man: an experimental study. J Clin Invest
1960; 39: 573–583.
286 W. LADOSKY ET AL.20. Cherniack RM. Respiratory effects of obesity. Can
Med Assoc J 1959; 80: 613–616.
21. Alexander JK, Amad KH, Cole VW. Observations on
some clinical features of extreme obesity, with parti-
cular reference to cardiorespiratory effects. Am J Med
1962; 32: 512–524.
22. Holley HS, Milic-Emili J, Becklake MR, Bates DV.
Regional distribution of pulmonary ventilation and
perfusion in obesity. J Clin Invest 1967; 46: 475–481.
23. Rubinstein I, Zamel N, DuBarry L, Hoffstein V.
Airflow limitation in morbidly obese, non-smoking
men. Annals Intern Med 1990; 112: 828–832.
24. Zerah F, Harf A, Perlemuter L, Lorino H, Lorino
A-M. Effects of obesity on respiratory resistance. Chest
1993; 103: 1470–1476.
25. Barrera F, Reidenberg MM, Winters WL. Pulmonary
function in the obese patients. Am J Med Sci 1967; 254:
785–796.
26. Vaughan RW, Cork RC, Hollander D. The effect of
massive weight loss on arterial oxygenation and
pulmonary function tests. Anesthesiology 1981; 54:
325–328.
27. SBPT. I Consenso Brasileiro de Espirometria.
J Pneumol 1966; 22: 105–156.
28. ATS. Lung function testing: selection of reference
values and interpretation strategies. Am Rev Resp Dis
1991; 144: 1202–1218.
29. Quanjer PH, Tammeling G, Cotes JE, Pedersen R,
Peslin R, Yernault J-C. Lung volumes and forced
ventilatory flows. Report working party standardisa-
tion of lung function tests. European Community
for Steel and Coal. Ocial statement of the
European Respiratory Society. Eur Resp J 1993; 16
(Suppl.): 5–40.
30. D’Angelo E, Prandi E, Marazzini L, Milic-Emili J.
Dependence of maximal Flow–volume curves on time
course of preceding inspiration in patients with chronic
obstructive pulmonary disease. Am J Resp Crit Care
Med 1994; 150: 1581–1586.
31. Pereira CAC, Barreto SP, Simo˜es JG, Pereira FWL,
Gerstler JG, Nakamura. Valores de refereˆncia paraespirometria em uma amostra da populac¸a˜o brasileira.
J Pneumol 1992; 18: 10–22.
32. Kory RC, Callaham R, Boren HG. The Veteran
Administration–Army Cooperative study of pulmon-
ary function I. Clinical spirometry in normal men. Am
Rev Resp Dis 1961; 30: 243–258.
33. Lindall A, Medina A, Grismer JT. A re-evaluation of
normal pulmonary function measurements in the adult
female. Am Rev Resp Dis 1967; 95: 1061–1064.
34. Rinqvist T. The ventilatory capacity in normal subjects:
an analysis of causal factors with special reference to
the respiratory forces. Scand J Lab Invest 1996;
88(Suppl.): 1–17.
35. Black LF, Hyatt RE. Maximal static respiratory
pressures in generalised neuromuscular disease. Am
Rev Resp Dis 1971; 103: 641–650.
36. Lavietes MH, Clifford E, Silverstein D. Relationship of
static respiratory muscle pressure and maximum
ventilatory ventilation. Respiration 1979; 38: 121–126.
37. Aldrich TK, Arora NS, Rochester DF. The influence of
airway obstruction and respiratory muscle strength on
maximal voluntary ventilation. Am Rev Resp Dis 1982;
126: 195–199.
38. Dillard TA, Pintadosi S, Rajagopal KR. Prediction of
ventilation at maximal exercise in chronic airflow
obstruction. Am Rev Resp Dis 1985; 132: 230–235.
39. Milic-Emili J, Grunstein MM. Drive and timing
components of ventilation. Chest 1976; 70: 131–133.
40. Hyatt RE, Wilson TA. Forced expiration in the lung,
Scientific Foundation. In: Crystal RC, West JB, Weibel
ER, Barnes PJ, eds. The Lung. Philadelphia: Lippin-
coft-Raver 1997; 1393–1401.
41. Krowka MJ, Enright PL, Rodarte RJ, Hyatt RE.
Effect of effort on measurement of forced expiratory
volume in one second. Am Rev Resp Dis 1987; 136:
829–833.
42. D’Angelo E, Milic-Emili J, Marazzini L. Effects of
bronchodilator tone and gas density on time depen-
dence of forced vital capacity manoeuvre. Am J Resp
Crit Care Med 1996; 154: 1318–1322.
